Lifecare ASA will publish its Q2 2025 results on Wednesday, 20 August 2025, at
07:00 CEST.
The company invites shareholders, investors, and other stakeholders to the
presentation of the second quarter results the same day at 10.45 CEST, to be
held at Scandic Flesland Airport Hotel, Bergen, Norway, in connection with the
event Vestland på Børs.
The results will be presented in English via a live webcast, followed by a Q&A
session. Participants will be able to submit questions online throughout the
webcast.
The webcast will be available at
https://lifecare.no/investor/reports-presentations/ and can also be accessed
here (https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20250820_14).
A recording of the webcast will be made available on the company's website
shortly after the event.
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's focus is to bring the next
generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is suitable for identifying and monitoring the occurrence of a wide
range of analytes and molecules in the human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42